Regenxbio Inc (NAS:RGNX)
$ 7.41 -0.46 (-5.84%) Market Cap: 367.13 Mil Enterprise Value: 218.52 Mil PE Ratio: 0 PB Ratio: 1.22 GF Score: 65/100

Regenxbio Inc at UBS Global Healthcare Virtual Conference Transcript

May 25, 2021 / 03:00PM GMT
Release Date Price: $33.54 (-2.27%)
Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director

Good morning, everyone, and thank you for joining us at the UBS Virtual Healthcare Conference Day 2.

I'm excited to have the REGENX management team here with us for a fireside chat, and we're joined by REGENX Chief Medical Officer, Steve Pakola; and Chief Scientific Officer, Olivier Danos.

Gentlemen, welcome, and thank you for making time for us.

Stephen Pakola
REGENXBIO Inc. - Senior VP & Chief Medical Officer

Good morning Esther. Thanks for the invitation. We're glad to be with -- here with you.

Olivier Danos
REGENXBIO Inc. - Senior VP & Chief Scientific Officer

Good morning.

Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director

And I apologize for not being on camera. We've had some technical difficulty. But perhaps, Steve, maybe you can start us off with what's on tap for the rest of the year and give us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot